Citation: | WANG Zhe, SUN Bo, REN Ping, HUANG Xi. Meranzin Hydrate Effects Atherosclerosis and Depressive Comorbidity in ApoE-/- Rats by Antidyslipidemic, Anti-Inflammatory and Regulate Intestinal Flora[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(6): 511-519. doi: 10.14148/j.issn.1672-0482.2022.0511 |
[1] |
LIBBY P. The changing landscape of atherosclerosis[J]. Nature, 2021, 592(7855): 524-533. doi: 10.1038/s41586-021-03392-8
|
[2] |
CREA F. The growing complexity of the number one killer: Ischaemic heart disease[J]. Eur Heart J, 2021, 42(26): 2513-2517. doi: 10.1093/eurheartj/ehab414
|
[3] |
TINETTI ME, FRIED TR, BOYD CM. Designing health care for the most common chronic condition-multimorbidity[J]. JAMA, 2012, 307(23): 1-12.
|
[4] |
LANG DM. Multimorbidity: The new normal[J]. Ann Am Thorac Soc, 2013, 10(5): 491-493. doi: 10.1513/AnnalsATS.201308-264ED
|
[5] |
WHITTY CJM, WATT FM. Map clusters of diseases to tackle multimorbidity[J]. Nature, 2020, 579(7800): 494-496. doi: 10.1038/d41586-020-00837-4
|
[6] |
TULLY PJ, BAUMEISTER H. Collaborative care for the treatment of comorbid depression and coronary heart disease: A systematic review and meta-analysis protocol[J]. Syst Rev, 2014, 3: 127. doi: 10.1186/2046-4053-3-127
|
[7] |
DE VRIES HE, KUIPER J, DE BOER AG, et al. The blood-brain barrier in neuroinflammatory diseases[J]. Pharmacol Rev, 1997, 49(2): 143-155.
|
[8] |
TANG WHW, WANG ZN, LEVISON BS, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk[J]. N Engl J Med, 2013, 368(17): 1575-1584. doi: 10.1056/NEJMoa1109400
|
[9] |
GANZ T. Antimicrobial polypeptides in host defense of the respiratory tract[J]. J Clin Invest, 2002, 109(6): 693-697. doi: 10.1172/JCI0215218
|
[10] |
ROMANO KA, VIVAS EI, AMADOR-NOGUEZ D, et al. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide[J]. mBio, 2015, 6(2): e02481.
|
[11] |
ZHANG Y, HUANG RR, CHENG MJ, et al. Gut microbiota from NLRP3-deficient mice ameliorates depressive-like behaviors by regulating astrocyte dysfunction via circHIPK2[J]. Microbiome, 2019, 7: 116. doi: 10.1186/s40168-019-0733-3
|
[12] |
TILG H, ZMORA N, ADOLPH TE, et al. The intestinal microbiota fuelling metabolic inflammation[J]. Nat Rev Immunol, 2020, 20(1): 40-54. doi: 10.1038/s41577-019-0198-4
|
[13] |
ADHIKARI-DEVKOTA A, KURAUCHI Y, YAMADA T, et al. Anti-neuroinflammatory activities of extract and polymethoxyflavonoids from immature fruit peels of Citrus "Hebesu"[J]. J Food Biochem, 2019, 43(6): e12813. doi: 10.1111/jfbc.12813
|
[14] |
XIE WB, QIU XJ, HUANG X, et al. Comparison between the pharmacokinetics of meranzin hydrate in a rat model of chronic depression and in controls following the oral administration of Chaihu-Shugan-San[J]. Exp Ther Med, 2013, 6(4): 913-918. doi: 10.3892/etm.2013.1229
|
[15] |
WANG WB, ZHAO LL, HUANG HY, et al. Development of an ultra-high performance liquid chromatography method for simultaneous determination of six active compounds in Fructus aurantii and rat plasma and its application to a comparative pharmacokinetic study in rats administered with different doses[J]. J Anal Methods Chem, 2018, 2018: 7579136.
|
[16] |
SHI SQ, YAN H, CHEN Y, et al. Pharmacokinetic study of precisely representative antidepressant, prokinetic, anti-inflammatory and anti-oxidative compounds from Fructus aurantii and Magnolia Bark[J]. Chem Biol Interact, 2020, 315: 108851. doi: 10.1016/j.cbi.2019.108851
|
[17] |
YU XB, ZHANG HN, DAI Y, et al. Simvastatin prevents and ameliorates depressive behaviors via neuroinflammatory regulation in mice[J]. J Affect Disord, 2019, 245: 939-949. doi: 10.1016/j.jad.2018.11.086
|
[18] |
LIU YL, WANG WK, CHEN Y, et al. Simultaneous quantification of nine components in the plasma of depressed rats after oral administration of Chaihu-Shugan-San by ultra-performance liquid chromatography/quadrupole-time-of-flight mass spectrometry and its application to pharmacokinetic studies[J]. J Pharm Biomed Anal, 2020, 186: 113310. doi: 10.1016/j.jpba.2020.113310
|
[19] |
CHEN SJ, ASAKAWA T, DING SS, et al. Chaihu-Shugan-San administration ameliorates perimenopausal anxiety and depression in rats[J]. PLoS ONE, 2013, 8(8): e72428. doi: 10.1371/journal.pone.0072428
|
[20] |
LI HT, LI YH, ZHANG XF, et al. The combination of Aquilaria sinensis (lour. ) gilg and Aucklandia costus falc. volatile oils exerts antidepressant effects in a CUMS-induced rat model by regulating the HPA axis and levels of neurotransmitters[J]. Front Pharmacol, 2021, 11: 614413. doi: 10.3389/fphar.2020.614413
|
[21] |
BIELIŃSKI M, LESIEWSKA N, BIELIŃSKA J, et al. Affective temperament in inflammatory bowel diseases: Another brick in the wall of differentiation[J]. PLoS ONE, 2018, 13(11): e0205606. doi: 10.1371/journal.pone.0205606
|
[22] |
JIA KK, PAN SM, DING H, et al. Chaihu-shugan san inhibits inflammatory response to improve insulin signaling in liver and prefrontal cortex of CUMS rats with glucose intolerance[J]. Biomed Pharmacother, 2018, 103: 1415-1428. doi: 10.1016/j.biopha.2018.04.171
|
[23] |
LIANG Y, ZHANG Y, DENG Y, et al. Chaihu-Shugan-San Decoction Modulates Intestinal Microbe Dysbiosis and Alleviates Chronic Metabolic Inflammation in NAFLD Rats via the NLRP3 Inflammasome Pathway[J]. Evid Based Complement Alternat Med, 2018, 2018: 9390786.
|
[24] |
LIU Q, SUN NN, WU ZZ, et al. Chaihu-Shugan-San exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways[J]. Neural Regen Res, 2018, 13(5): 837-845. doi: 10.4103/1673-5374.232478
|
[25] |
QIU J, HU SY, SHI GQ, et al. Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression[J]. Pharmacogn Mag, 2014, 10(40): 503-508. doi: 10.4103/0973-1296.141775
|
[26] |
KANG S, LEE S, KIM J, et al. Chronic treatment with combined chemotherapeutic agents affects hippocampal micromorphometry and function in mice, independently of neuroinflammation[J]. Exp Neurobiol, 2018, 27(5): 419-436. doi: 10.5607/en.2018.27.5.419
|
[27] |
ZHANG TR, LAROSA A, DI RADDO ME, et al. Negative memory engrams in the Hippocampus enhance the susceptibility to chronic social defeat stress[J]. J Neurosci, 2019, 39(38): 7576-7590. doi: 10.1523/JNEUROSCI.1958-18.2019
|
[28] |
AZEVEDO EP, POMERANZ L, CHENG J, et al. A role of Drd2 hippocampal neurons in context-dependent food intake[J]. Neuron, 2019, 102(4): 873-886. doi: 10.1016/j.neuron.2019.03.011
|
[29] |
FERRAGUD A, VELÁZQUEZ-SÁNCHEZ C, ABDULLATIF AA, et al. Withdrawal from extended, intermittent access to A highly palatable diet impairs hippocampal memory function and neurogenesis: Effects of memantine[J]. Nutrients, 2020, 12(5): 1520. doi: 10.3390/nu12051520
|
[30] |
BAUMGARNER KM, SETTI S, DIAZ C, et al. Diet-induced obesity attenuates cytokine production following an immune challenge[J]. Behav Brain Res, 2014, 267: 33-41. doi: 10.1016/j.bbr.2014.03.017
|
[31] |
GUILLEMOT-LEGRIS O, MUCCIOLI GG. Obesity-induced neuroinflammation: Beyond the hypothalamus[J]. Trends Neurosci, 2017, 40(4): 237-253. doi: 10.1016/j.tins.2017.02.005
|
[32] |
BROWN JM, HAZEN SL. Microbial modulation of cardiovascular disease[J]. Nat Rev Microbiol, 2018, 16(3): 171-181. doi: 10.1038/nrmicro.2017.149
|
[33] |
MA JL, LI HK. The role of gut microbiota in atherosclerosis and hypertension[J]. Front Pharmacol, 2018, 9: 1082. doi: 10.3389/fphar.2018.01082
|
[34] |
MAES M, KUBERA M, LEUNIS JC. The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression[J]. Neuro Endocrinol Lett, 2008, 29(1): 117-124.
|
[35] |
MAES M, KUBERA M, LEUNIS JC, et al. In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS-damaged neoepitopes[J]. Acta Psychiatr Scand, 2013, 127(5): 344-354. doi: 10.1111/j.1600-0447.2012.01908.x
|
[36] |
DUTTAROY AK. Role of gut microbiota and their metabolites on atherosclerosis, hypertension and human blood platelet function: A review[J]. Nutrients, 2021, 13(1): 144. doi: 10.3390/nu13010144
|
[37] |
LIU QF, KIM HM, LIM S, et al. Effect of probiotic administration on gut microbiota and depressive behaviors in mice[J]. DARU J Pharm Sci, 2020, 28(1): 181-189. doi: 10.1007/s40199-020-00329-w
|
[38] |
GERSHON MD, TACK J. The serotonin signaling system: From basic understanding to drug development for functional GI disorders[J]. Gastroenterology, 2007, 132(1): 397-414. doi: 10.1053/j.gastro.2006.11.002
|
[39] |
SUN QH, LIU ZJ, ZHANG L, et al. Sex-based differences in fecal short-chain fatty acid and gut microbiota in irritable bowel syndrome patients[J]. J Dig Dis, 2021, 22(5): 246-255. doi: 10.1111/1751-2980.12988
|
[40] |
LYU M, WANG YF, FAN GW, et al. Balancing herbal medicine and functional food for prevention and treatment of cardiometabolic diseases through modulating gut microbiota[J]. Front Microbiol, 2017, 8: 2146. doi: 10.3389/fmicb.2017.02146
|
[41] |
ROOPCHAND DE, CARMODY RN, KUHN P, et al. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome[J]. Diabetes, 2015, 64(8): 2847-2858. doi: 10.2337/db14-1916
|
[42] |
ZHU HZ, LIANG YD, MA QY, et al. Xiaoyaosan improves depressive-like behavior in rats with chronic immobilization stress through modulation of the gut microbiota[J]. Biomed Pharmacother, 2019, 112: 108621. doi: 10.1016/j.biopha.2019.108621
|